The more prominent role of β1AR in counter-acting α2AR auto inhibition of catecholamine release in SHR may explain why β1AR blockers are useful as antihypertensive medication and protective in myocardial infarction and heart failure. This evidence concerns the gene ADRB1 and myocardial infarction.